FindTrial
Sign In

Endoscopic diagnosis and treatment of submucosal mass in upper digestive tract

Endoscopic diagnosis and treatment of submucosal mass in upper digestive tract

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027339
Enrollment
Unknown
Registered
2019-11-09
Start date
2019-11-10
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal mass in upper digestive tract

Interventions

Case series:digestive endoscopy treatment

Sponsors

Nanfang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 year old patients; 2. Patients with a high degree of diagnosis of gastric stromal tumors, such as diagnostics or endoscopic CT; 3. The patient voluntarily signed the informed consent form and has been verbally informed of the specific protocol;a.

Exclusion criteria

Exclusion criteria: 1. Patients with gastric stromal tumors who are unable to undergo laparoscopic surgery with distant metastases; 2. Combine serious primary diseases of heart, cerebrovascular, liver, kidney and hematopoietic system; 3. Gastric stromal tumors with severe gastrointestinal bleeding are life-threatening and require immediate surgical treatment; 4. The investigators believe that it is not suitable for this tester.

Design outcomes

Primary

MeasureTime frame
Complete resection rate;—

Secondary

MeasureTime frame
Operation time;Recurrence rate;—

Countries

China

Contacts

Public ContactBai Lan

Nanfang Hospital of Southern Medical University

Bailan99@hotmail.com+86 020-61641539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026